PubMed HealthSearch

PubMed · 1343214

Computed tomography with monochromatic x rays.

Abstract

Recent advances in the development of synchrotron facilities that provide high-energy and high-flux x-ray beams allow the use of monochromatic x rays at a < 0.5% energy bandwidth (i.e. energy width of < 500 eV at 100 keV) for computed tomography (CT) of humans. Such CT systems will consist of a fixed, horizontal, low-divergence fan beam and a seated subject rotating about a vertical axis. Compared to conventional CT, the new system should significantly improve contrast resolution of the image and provide better image quantification because of its lack of beam-hardening effects and its efficient implementation of energy-selective imaging methods such as dual-photon absorptiometry and K-edge subtraction with high-atomic-number (high-Z) contrast-enhancement elements. Further, the nearly parallel synchrotron x-ray beam geometry minimizes patient-to-detector scattering when the detector is positioned far from the patient. The design considerations and the expected performance of monochromatic CT are described, in particular those of the CT being developed at the National Synchrotron Light Source. The potential applications of the method in neuroradiology, cardiac and vascular imaging, bone densitometry, lung imaging, and radiotherapy are discussed. The future of monochromatic CT in research and in clinical diagnostics is also reviewed, as are the prospects for development of compact sources of x rays with narrow-energy bandwidths.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F A Dilmanian. Computed tomography with monochromatic x rays.. https://pubmed.ncbi.nlm.nih.gov/1343214/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density.

BACKGROUND: The level of urinary, type I collagen, crosslinked N-telopeptides (NTX) is a new marker of bone resorption. To our knowledge, no population-based studies of older adults have determined whether this measure can identify individuals with osteoporosis. OBJECTIVES: To measure the levels of NTX in a cross-sectional study of ambulatory, older, white adults and to evaluate whether this measure of bone resorption could identify individuals with osteoporosis. PATIENTS AND METHODS: The subjects, aged 50 to 98 years, formed 3 groups: 374 men, 223 women currently using estrogen, and 364 women not currently using estrogen. A standard medical history and validated record of medication use were obtained. Height and weight were measured. Bone mineral density (BMD) was measured at the hip and lumbar spine using dual energy x-ray absorptiometry. The levels of NTX were measured by enzyme-linked immunosorbent assay. RESULTS: Overall, the levels of NTX increased slightly with age in men and in estrogen users and more dramatically in nonestrogen users. In a model adjusted for all major risk factors for osteoporosis, there was a significant decrease in BMD levels by increasing quintiles of NTX levels at the hip and spine in women with and without estrogen use and at the hip in men. Using sex-specific, peak bone mass criteria and age-adjusted analyses, the levels of NTX discriminated between normal (< or = -1.0 SD), osteopenic (> -1.0 and < -2.5 SD), and osteoporotic (> or = -2.5 SD) BMD levels in all groups except the spine in men. CONCLUSIONS: The levels of NTX uniquely discriminated between older adults with normal, osteopenic, or osteoporotic BMD levels. If confirmed, these data suggest that NTX levels could be used to predict current osteoporosis in older men and women.

Absorptiometry, Photon

Use of surface-modifying macromolecules to enhance the biostability of segmented polyurethanes.

Polyurethanes are widely used as biomaterials for medical implants because of their excellent mechanical properties and moderate biocompatibility. However, the demand for more bioresistant and biocompatible polyurethanes to meet the needs of long-term implant devices still remains an important issue. Since most biological interactions with materials occur at the interface, a significant number of studies for improving the biocompatibility of polyurethanes have concentrated on surface modification. It is well known that additives used in polymeric materials as processing aids, mold releasing agents, antioxidants, etc., migrate to the surface and change the surface properties of the material. Under certain conditions polymeric additives may also migrate toward surfaces. This study describes two fluorine-containing, surface-modifying macromolecules (SMMs) that have been evaluated for their ability to inhibit polyurethane degradation. These materials actively migrate to the upper surface of a material film when they are mixed with a base polymeric materia. Contact angle measurements for the mixture of SMM with base polyurethane indicate that the surface becomes more hydrophobic after adding the SMMs, while X-ray photoelectron spectroscopy analysis shows an enrichment of fluorine on the polymer surfaces. Differential scanning calorimetry thermograms indicate that the micro-structure, as defined by the thermal transitions of the base polymer, are not altered by the addition of SMMs. Enzyme-induced biodegradation tests exhibit a significant reduction of polyurethane degradation in the presence of these surface-resident materials. The results indicate that the SMMs have the potential to resist hydrolytic degradation mediated by lysosomal enzymes while generating a surface chemistry on the native elastomer which is similar in nature to that of a fluoropolymer, e.g., Teflon.

Absorptiometry, Photon